[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ptc Therapeutics (PTCT)

Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,264,308
  • Shares Outstanding, K 82,949
  • Annual Sales, $ 1,731 M
  • Annual Income, $ 682,640 K
  • EBIT $ -25 M
  • EBITDA $ -3 M
  • 60-Month Beta 0.53
  • Price/Sales 3.57
  • Price/Cash Flow 8.49
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 54.96% (-8.23%)
  • Historical Volatility 44.75%
  • IV Percentile 56%
  • IV Rank 44.96%
  • IV High 77.63% on 04/24/26
  • IV Low 36.45% on 01/21/26
  • Expected Move (DTE 21) 3.32 (4.87%)
  • Put/Call Vol Ratio 0.07
  • Today's Volume 954
  • Volume Avg (30-Day) 423
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 15,900
  • Open Int (30-Day) 13,488
  • Expected Range 64.70 to 71.33

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $0.07
  • Number of Estimates 3
  • High Estimate $0.18
  • Low Estimate $-0.12
  • Prior Year $0.20
  • Growth Rate Est. (year over year) -65.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
64.57 +5.33%
on 07/31/26
90.87 -25.16%
on 07/09/26
-13.56 (-16.62%)
since 06/30/26
3-Month
63.18 +7.64%
on 05/01/26
90.87 -25.16%
on 07/09/26
+2.95 (+4.53%)
since 04/30/26
52-Week
43.17 +57.52%
on 08/11/25
90.87 -25.16%
on 07/09/26
+17.07 (+33.51%)
since 07/30/25

Most Recent Stories

More News
PTC Therapeutics: Q2 Earnings Snapshot

PTC Therapeutics: Q2 Earnings Snapshot

PTCT : 68.01 (-9.94%)
PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results

– Robust Q2 performance with total revenue of $361 million, including $239 million of product revenue –

PTCT : 68.01 (-9.94%)
Can PTC Therapeutics Finally Turn Analyst Enthusiasm Into a Quarterly Win?

Barchart Research What to Expect from PTCT Earnings PTCT Generated July 29, 2026 Current Price $74.49 EPS Estimate $$-0.16 Consensus Rating Moderate Buy Average Move 7.47% Can PTC Therapeutics Finally...

PTCT : 68.01 (-9.94%)
Hamilton Lane Board Elects Michael Schmertzler as New Independent Director

CONSHOHOCKEN, Pa. , July 23, 2026 /PRNewswire/ -- Leading private markets investment management firm Hamilton Lane (Nasdaq: HLNE) announced that its Board of Directors elected Michael Schmertzler...

PTCT : 68.01 (-9.94%)
HLNE : 88.91 (-0.04%)
PTC Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, July 30, 2026

WARREN, N.J. , July 16, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the company will host a webcast conference call to report its second quarter 2026 financial...

PTCT : 68.01 (-9.94%)
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WARREN, N.J. , June 17, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on June 11, 2026, the company approved non-statutory stock options to purchase an aggregate...

PTCT : 68.01 (-9.94%)
PTC Therapeutics Announces Pricing of Convertible Notes Offering to Refinance 2026 Convertible Notes

– Refinancing transaction with proceeds to be utilized to repurchase or repay the 2026 convertible notes prior to or at maturity –

PTCT : 68.01 (-9.94%)
PTC Therapeutics Announces Proposed Convertible Notes Offering to Refinance 2026 Convertible Notes

– Proceeds to be used to repurchase or repay 2026 convertible notes prior to or at maturity –

PTCT : 68.01 (-9.94%)
PTC Therapeutics Q1 Earnings Call Highlights

PTC Therapeutics (NASDAQ:PTCT) reported a record first quarter for product revenue and raised its 2026 revenue outlook, citing strong early demand for Sephience, its treatment for phenylketonuria, or PKU.Chief...

PTCT : 68.01 (-9.94%)
PTC Therapeutics: Q1 Earnings Snapshot

PTC Therapeutics: Q1 Earnings Snapshot

PTCT : 68.01 (-9.94%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 30%. The market has entered oversold territory.

See More Share

Business Summary

PTC Therapeutics, Inc. is a biopharmaceutical company. It is focused on the discovery and development of orally administered, small-molecule drugs for genetic disorders, oncology and infectious disease. PTC Therapeutics, Inc. is based in South Plainfield, United States.

See More

Key Turning Points

3rd Resistance Point 82.12
2nd Resistance Point 77.92
1st Resistance Point 72.96
Last Price 68.01
1st Support Level 63.81
2nd Support Level 59.61
3rd Support Level 54.66

See More

52-Week High 90.87
Fibonacci 61.8% 72.65
Last Price 68.01
Fibonacci 50% 67.02
Fibonacci 38.2% 61.39
52-Week Low 43.17

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.